Reaction
Aortitis reporting signals
As of the last recalculation, Aortitis appears in 673 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is FILGRASTIM (PRR 56.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Filgrastim | 62 | 56.0 | 56.1 |
| Pegfilgrastim | 134 | 52.2 | 52.3 |
| Docetaxel Anhydrous | 91 | 48.1 | 48.2 |
| Docetaxel | 91 | 48.1 | 48.2 |
| Granisetron Hydrochloride | 15 | 45.4 | 45.5 |
| Granisetron | 11 | 33.0 | 33.0 |
| Dexamethasone Sodium Phosphate | 10 | 30.9 | 30.9 |
| Pertuzumab | 22 | 25.8 | 25.9 |
| Pemetrexed | 17 | 25.1 | 25.1 |
| Aprepitant | 13 | 22.2 | 22.2 |
| Trastuzumab | 43 | 20.6 | 20.6 |
| Carboplatin | 72 | 19.5 | 19.5 |
| Paclitaxel (Aibumin-Bound) | 45 | 18.1 | 18.1 |
| Fluorouracil Cream, 0.5% | 41 | 17.6 | 17.6 |
| Fluorouracil | 41 | 17.4 | 17.4 |
| Pemetrexed Disodium | 20 | 16.7 | 16.7 |
| Paclitaxel | 45 | 15.0 | 15.0 |
| Oxaliplatin | 34 | 14.9 | 14.9 |
| Cisplatin | 33 | 13.7 | 13.7 |
| Irinotecan Hydrochloride | 4 | 9.7 | 9.7 |